Protocol
Liraglutide (Saxenda): The Daily Option
Before Ozempic, there was Saxenda. Liraglutide is the daily-injection GLP-1 agonist with a proven track record.
ByPeptide Bioregulator Atlas (Adapted)
April 18, 2024
Before Ozempic, there was Saxenda. Liraglutide is the daily-injection GLP-1 agonist with a proven track record.